OCGN is a bio medical company that is extremely undervalued. We will see a huge buy order in this week. OCGN has a great potential to go to 190$ in near future.
OCGN Ocugen partnered with Bharat Biotech for Covaxin, the first COVID vaccine developed in India to receive emergency authorization.
With the COVID significant rise in cases, hospitalizations and deaths over the last two weeks, vaccines producers are rising once again.
My short term Price Target is 10.30usd
